Yekaterinburg, Ekaterinburg, Russian Federation
Yekaterinburg, Ekaterinburg, Russian Federation
Yekaterinburg, Ekaterinburg, Russian Federation
. Myocardial contraction is the result of the interaction of myosin, which makes up the thick filament, with actin, which forms the basis of the thin filament, and is regulated by calcium through the regulatory proteins troponin and tropomyosin. Recently, it was found that, in addition to regulatory proteins, cardiac myosin-binding protein-C (cMyBP-C) is involved in the regulation of actin-myosin interaction. cMyBP-C is one of the integral proteins of the cardiomyocyte sarcomere, which has binding sites for the main sarcomere proteins, myosin, actin, and tropomyosin. cMyBP-C controls the number of myosin heads interacting with the thin filament and participates in its activation. In this work, the influence of cMyBP-C on the characteristics of a single actin-myosin interaction, myosin step size and interaction duration, was studied using an optical trap method. Cardiac myosin was extracted from rabbit left ventricular myocardium, actin was isolated from rabbit fast skeletal muscle, and cMyBP-C was obtained from chicken ventricles. cMyBP-C was added to cardiac myosin in a physiological ratio of 1:5. In an in vitro motility assay, the addition of cMyBP-C was found to slow actin sliding velocity over myosin by 30%. It was found that cMyBP-C does not affect step size of myosin but increases the duration of its interaction with the actin filament. The results obtained indicate a direct effect of cMyBP-C on a single actin-myosin interaction.
cardiac myosin-binding protein C, actin-myosin interaction, myocardium, optical trap
1. Freiburg A., Gautel M. A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. Eur. J. Biochem., 1996, no. 235, pp. 317-323, doi:https://doi.org/10.1111/j.1432-1033.1996.00317x.
2. Okagaki T., Weber F.E., Fischman D.A., Vaughan K.T., Mikawa T., Reinach. The major myosin-binding domain of skeletal muscle MyBP-C (C protein) resides in the COOH-terminal, immunoglobulin C2 motif. J. Cell. Biol., 1993, no. 123, pp. 619-626, doi:https://doi.org/10.1083/jcb.123.3.619.
3. Starr R., Offer G. The interaction of C-protein with heavy meromyosin and subfragment-2. Biochem. J., 1978, no. 171, pp. 813-816, doi:https://doi.org/10.1042/bj1710813.
4. Gruen M., Gautel M. Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C. J. Mol. Biol., 1999, no. 286, pp. 933-949, doi:https://doi.org/10.1006/jmbi.1998.2522.
5. Squire J.M., Luther P.K., Knupp C. Structural evidence for the interaction of C-protein (MyBP-C) with actin and sequence identification of a possible actin-binding domain. J. Mol. Biol, 2003, no. 331, pp. 713-724, doi:https://doi.org/10.1016/s0022-2836(03)00781-2.
6. Moos C., Mason C.M., Besterman J.M., Feng I.N., Dubin J.H. The binding of skeletal muscle C-protein to F-actin, and its relation to the interaction of actin with myosin subfragment-11. J. Mol. Biol., 1978, no 124, pp. 571-586, doi:https://doi.org/10.1016/0022-2836(78)90172-9.
7. Mun J.Y., Previs M.J., Yu H.Y., Gulick J., Tobacman L.S., Previs S.B., Robbins J., Warshaw D.M., Craig R. Myosin-binding protein C displaces tropomyosin to activate cardiac thin flaments and governs their speed by an independent mechanism. Proc. Natl. Acad. Sci. USA, 2014, no. 111, pp. 2170-2175, doi:https://doi.org/10.1073/pnas.1316001111.
8. Wang L., Geist J., Grogan A., Hu L.R., Kontrogianni-Konstantopoulos A. Thick filament protein network, functions, and disease association. Compr. Physiol., 2018, no. 8, pp. 631-709, doi:https://doi.org/10.1002/cphy.c170023.
9. Matyushenko A.M., Shchepkin D.V., Kopylova G.V., Popruga K.E., Artemova N.V., Pivovarova A.V., Bershitsky S.Y., Levitsky D.I. Structural and functional effects of cardiomyopathy-causing mutations in the troponin T-binding region of cardiac tropomyosin. Biochemistry, 2017, no. 56, pp. 250-259, doi:https://doi.org/10.1021/acs.biochem.6b00994.
10. Nabiev S.R., Ovsyannikov D.A., Tsaturyan A.K., Bershitsky S.Y. The lifetime of the actomyosin complex in vitro under load corresponding to stretch of contractile muscle. Eur. Biophys. J., 2015, no. 44, pp. 457-463, doi:https://doi.org/10.1007/s00249-015-1048-3.
11. Finer J.T., Simmons R.M., Spudich J.A. Single myosin molecule mechanics: piconewton forces and nanometer steps. Nature, 1994, no. 368, pp. 113-119, doi:https://doi.org/10.1038/368113a0.
12. Haeberle J.R. Calponin decreases the rate of cross-bridge cycling and increases maximum force production by smoothe muscle myosin in an in vitro motility assay. J. Biol. Chem., 1994, no. 269, pp. 12424-12431.
13. Knight A.E., Veigel C., Chambers C., Molloy J.E. Analisys of single-molecule mechanical recordings: application to acto-myoin interactions. Prog. Biophys. Mol. Biol., 2001, no. 77, pp. 45-72, doi:https://doi.org/10.1016/s0079-6107(01)00010-4.
14. Shchepkin D.V., Kopylova G.V., Nikitina L.V., Katsnelson L.B., Bershitsky S.Y. Effects of cardiac myosin binding protein-C on the regulation of interaction of cardiac myosin with thin filament in an in vitro motility assay. Biochem Biophys Res Commun, 2010, no. 401, pp. 159-163, doi:https://doi.org/10.1016/j.bbrc.2010.09.040.
15. Alpert N.R., Brosseau C., Federico A., Krenz M., Robbins J., Warshaw D. M. Molecular mechanics of mouse cardiac myosin isoforms. Am. J. Physiol. Heart Circ. Physiol., 2002, no. 283, pp. 1446-1454, doi:https://doi.org/10.1152/ajpheart.00274.2002.
16. Palmiter K.A., Tyska M.J., Dupius D.E., Alpert N.R., Warshaw D.M. Kinetic differences at the single molecule level account for the functional diversity of rabbit cardiac myosin isoforms. J. Physiol., 1999, no. 519, pp. 669-678, doi:https://doi.org/10.1111/j.1469-7793.1999.0669n.x.
